INBS — INTELLIGENT BIO SOLUTIONS IN
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $4.5M | +36.5% | -$12.1M | — | -160.2% | 54.5% | -191.0% | — | — | — | — |
Revenue YoY trend Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Jun 2027 | -5.18 | — | -5.18 | -5.18 | 1 | — |
| Jun 2028 | -4.06 | — | -4.06 | -4.06 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 9 SEC-registered investment managers reported holding INBS (INTELLIGENT BIO SOLUTIONS IN) in their latest 13F filings, with a combined reported value of $201.91K across 118.62K shares. That is -6.2% by share count (-2.46K shares) versus the previous quarter, while reported value moved -31.7%. Ownership is concentrated: the five largest holders account for 97.6% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 1 added to existing stakes, 3 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of INTELLIGENT BIO SOLUTIONS IN (INBS) include Hudson Bay Capital Management LP, ADAR1 Capital Management, LLC, ARMISTICE CAPITAL, LLC, ranked by reported 13F value among the 38 institutional holders on this page.
INBS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 9 | 118.62K | $201.91K | -6.2% |
| Q2 2026 | 9 | 202.20K | $464.05K | +6.5% |
| Q1 2026 | 9 | 208.35K | $696.95K | -67.0% |
| Q4 2025 | 7 | 5.66K | $53.02K | -97.3% |
| Q3 2025 | 12 | 1.35M | $1.38M | +21.5% |
| Q2 2025 | 9 | 707.62K | $1.22M | +0.2% |
| Q1 2025 | 9 | 877.16K | $1.26M | +45.3% |
| Q4 2024 | 8 | 76.82K | $107.55K | +24.5% |
Over the 8 quarters shown, institutional share counts increased 54% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (-97.3%).
Top Institutional Holders (Q3 2026) — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 70.03K | $116.96K | 0.00% | New | |
| 17.88K | $29.86K | 0.00% | Reduce | |
| 11.22K | $22.55K | 0.00% | New | |
| 12.60K | $21.05K | 0.00% | Add | |
| 3.96K | $6.61K | 0.00% | Hold | |
| 1.36K | $2.28K | 0.00% | Reduce | |
| 1.35K | $2.26K | 0.00% | Reduce | |
| 200 | $326 | 0.00% | Hold | |
| 13 | $21 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 141.40K | $324.51K | 0.00% | Add | |
| 20.84K | $47.83K | 0.00% | New | |
| 20.84K | $47.83K | 0.00% | Reduce | |
| 5.81K | $13.33K | 0.00% | Hold | |
| 5.74K | $13.16K | 0.00% | Add | |
| 3.96K | $9.08K | 0.00% | Hold | |
| 3.28K | $7.53K | 0.00% | Add | |
| 200 | $460 | 0.00% | Hold | |
| 142 | $326 | 0.00% | New |
Q1 2026 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 130.00K | $434.85K | 0.01% | New | |
| 37.96K | $126.96K | 0.00% | New | |
| 28.61K | $95.70K | 0.00% | New | |
| 5.81K | $19.43K | 0.00% | New | |
| 3.96K | $13.24K | 0.00% | New | |
| 1.25K | $4.18K | 0.00% | Reduce | |
| 372 | $1.24K | 0.00% | Reduce | |
| 200 | $670 | 0.00% | New | |
| 200 | $669 | 0.00% | Hold |
Q4 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.05K | $38.63K | 0.00% | New | |
| 1.26K | $12.01K | 0.00% | New | |
| 200 | $996 | 0.00% | Reduce | |
| 76 | $724 | 0.00% | Reduce | |
| 35 | $332 | 0.00% | Reduce | |
| 25 | $238 | 0.00% | New | |
| 9 | $86 | 0.00% | Reduce |
Q3 2025 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 673.49K | $686.96K | 0.00% | Add | |
| 426.43K | $434.96K | 0.04% | New | |
| 97.69K | $99.64K | 0.00% | Add | |
| 58.87K | $60.05K | 0.00% | Add | |
| 44.69K | $45.59K | 0.01% | New | |
| 25.00K | $25.50K | 0.00% | New | |
| 12.83K | $13.09K | 0.00% | Hold | |
| 9.35K | $9.54K | 0.00% | New | |
| 2.64K | $2.69K | 0.00% | Add | |
| 2.00K | $2.04K | 0.00% | New | |
| 350 | $354 | 0.00% | Hold | |
| 64 | $65 | 0.00% | Add |
Q2 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 613.89K | $1.06M | 0.00% | Hold | |
| 51.45K | $88.50K | 0.00% | Add | |
| 15.48K | $26.63K | 0.00% | Hold | |
| 12.83K | $22.06K | 0.00% | Hold | |
| 10.90K | $18.75K | 0.00% | New | |
| 2.35K | $4.00K | 0.00% | New | |
| 350 | $598 | 0.00% | New | |
| 300 | $516 | 0.00% | Reduce | |
| 63 | $108 | 0.00% | Add |
New Positions (Q3 2026)
- Alyeska Investment Group, L.P. 70.03K sh · $116.96K
- StoneX Group Inc. 11.22K sh · $22.55K
- JPMorgan Chase & Co 13 sh · $21
Fully Exited (vs previous quarter)
- ARMISTICE CAPITAL, LLC sold 141.40K sh · $324.51K
- GEODE CAPITAL MANAGEMENT, LLC sold 20.84K sh · $47.83K
- BARCLAYS PLC sold 142 sh · $326
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 70.03K | — | 37.96K | — | 673.49K | 613.89K | 613.89K | — | 206.20K | 222.91K | 206.20K | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 17.88K | 20.84K | 28.61K | — | 58.87K | 51.45K | 49.01K | 26.60K | 22.71K | 19.06K | 14.32K | 12.41K | 12.41K | — | — | 115.36K | 115.83K | 115.83K | 113.12K | — |
| StoneX Group Inc. | 11.22K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.60K | 5.81K | 5.81K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 3.96K | 3.96K | 3.96K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 1.36K | 5.74K | 372 | 4.05K | — | 300 | 1.17K | 2.90K | 1.55K | 8.32K | 348 | — | — | — | 613 | 10.76K | 759 | 12.66K | 11.20K | 9.12K |
| Tower Research Capital LLC (TRC) | 1.35K | 3.28K | 1.25K | 1.26K | — | — | — | 5.80K | 1.06K | 654 | 1.05K | 25.35K | 5.95K | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 200 | 200 | 200 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 13 | — | — | — | — | — | — | — | — | — | 4 | — | — | — | — | — | — | — | — | — |
| ADAR1 Capital Management, LLC | — | — | — | — | 426.43K | — | — | — | 5.39K | 108.25K | 108.25K | — | — | — | — | — | — | — | — | — |
| Hudson Bay Capital Management LP | — | — | — | — | — | — | — | — | — | — | 108.25K | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | 141.40K | 130.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Altium Capital Management LLC | — | — | — | — | — | — | 149.25K | — | — | 83.91K | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | — | 97.69K | 15.48K | 15.48K | 15.48K | 15.48K | 15.48K | 15.48K | — | — | — | — | 16.92K | 16.45K | 16.45K | — | 38.92K |
| Renaissance Technologies | — | — | — | — | — | 10.90K | — | — | — | — | — | 147.57K | — | — | — | 104.80K | 107.00K | 111.90K | 67.50K | — |
| Citadel Advisors | — | — | — | — | — | — | — | — | — | — | 14.84K | 156.39K | — | — | — | 69.48K | 34.57K | — | 29.42K | — |
| Virtu Financial LLC | — | — | — | — | — | — | — | — | — | — | 12.54K | — | — | — | — | — | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | — | — | — | — | — | 35.49K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 20.84K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Warberg Asset Management LLC | — | — | — | — | 44.69K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold INBS?
As of 2026-Q3, 9 institutional funds reported holding INBS (INTELLIGENT BIO SOLUTIONS IN) in SEC 13F filings, with a combined reported value of $201.91K.
How many shares of INBS do institutions own?
13F filers reported 118.62K shares of INBS, worth $201.91K in aggregate at the end of 2026-Q3.
Is institutional ownership of INBS rising or falling?
Share counts moved -6.2% versus the prior quarter — distribution.
Who are the top institutional holders of INBS?
The largest 13F holders are Hudson Bay Capital Management LP, ADAR1 Capital Management, LLC, ARMISTICE CAPITAL, LLC, Altium Capital Management LLC, Alyeska Investment Group, L.P.; the top 25 are ranked at the top of this page.
Who are the major shareholders of INTELLIGENT BIO SOLUTIONS IN?
The major shareholders of INTELLIGENT BIO SOLUTIONS IN (INBS) by reported 13F value are Hudson Bay Capital Management LP, ADAR1 Capital Management, LLC, ARMISTICE CAPITAL, LLC, Altium Capital Management LLC, Alyeska Investment Group, L.P., among 38 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.